Gerald Baker Financial Group’s Novartis NVS Stock Holding History

Gerald Baker Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Hold	2,194	–	–	0.1%	103
2026 Q1	$335K	Buy	+2,194	New	+$336K	0.11%	95

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Gerald Baker Financial Group's NVS Position: Q2 2026 in Review

Gerald Baker Financial Group held its Novartis (NVS) position steady in Q2 2026 at 2,194 shares worth $344K. The position accounts for 0.1% of the portfolio, ranked #103.

Gerald Baker Financial Group first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Gerald Baker Financial Group held 2,194 shares of Novartis worth $344K as of Q2 2026.
Gerald Baker Financial Group left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.1% of Gerald Baker Financial Group's portfolio in Q2 2026, its #103 holding.
Gerald Baker Financial Group first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Gerald Baker Financial Group's 13F filing for Q2 2026, filed 3 Aug 2026.